AQP4 and synovial sarcoma: This case report represents a significant finding that inebilizumab in AQP4-IgG seropositive NMOSD patient not only improves symptoms of NMOSD and reduces disease relapses but also effectively alleviates symptoms of concurrent SS and pancytopenia.